Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Hims & Hers Health, Inc. (HIMS) vs Viatris Inc. (VTRS)

Hims & Hers Health, Inc. and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $20.0B against $6.9B — 2.9× the size. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 4.40%. Viatris Inc. has the higher net margin (−2.79% vs −5.51%) and the higher return on invested capital (−0.20% vs −11.4%). Across the 19 metrics below, Viatris Inc. leads on 14 and Hims & Hers Health, Inc. on 5.

Valuation

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.65 1.41 2.25
P/B 21.07 1.45 1.90
Price to free cash flow 82.23 10.97 16.54
EV/EBITDA n/m 12.22 12.29
EV/Sales 2.85 2.25 2.56
Earnings yield (2.07%) (2.02%) (2.99%)
Free cash flow yield 1.22% 9.11% 0.00%

Profitability

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
Gross margin 68.43% 34.83% 53.94%
Operating margin (5.99%) (0.59%) 0.00%
Net margin (5.51%) (2.79%) 0.00%
Free cash flow margin 3.22% 12.83% 0.00%
Return on equity (32.03%) (2.75%) (0.40%)
Return on assets (5.16%) (1.12%) (3.32%)
Return on invested capital (11.38%) (0.20%) 0.00%

Growth

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 28.04% 4.40% 10.01%
EPS growth (last fiscal year) (3.77%) (466.04%) —
Revenue growth, 5-year CAGR 53.90% 3.66% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 4.21 0.94 0.05
Current ratio 0.93 1.58 2.31
Net debt to EBITDA 2.43 4.92 0.85

Dividend

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
Dividend yield — 4.15% 1.70%
Payout ratio 0.00 0.31 0.00

Size

Metric HIMS VTRS Drug Manufacturers Specialty & Generic median
Market cap 6.87b 19.99b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack